BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36031998)

  • 1. A simple model to estimate the transmissibility of the Beta, Delta, and Omicron variants of SARS-COV-2 in South Africa.
    Yu Y; Yu Y; Zhao S; He D
    Math Biosci Eng; 2022 Jul; 19(10):10361-10373. PubMed ID: 36031998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa.
    Liu Y; Yu Y; Zhao Y; He D
    Int J Infect Dis; 2022 Jul; 120():146-149. PubMed ID: 35462038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron).
    Yang W; Shaman JL
    Elife; 2022 Aug; 11():. PubMed ID: 35943138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    Wolf JM; Wolf LM; Bello GL; Maccari JG; Nasi LA
    J Med Virol; 2023 Jan; 95(1):e28366. PubMed ID: 36458547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Preliminary Genomic Analysis of the Omicron Variants of SARS-CoV-2 in Central India During the third wave of the COVID-19 Pandemic.
    Singh P; Negi SS; Bhargava A; Kolla VP; Arora RD
    Arch Med Res; 2022 Sep; 53(6):574-584. PubMed ID: 36123226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tentative assessment of the changes in transmissibility and fatality risk associated with Beta SARS-CoV-2 variants in South Africa: an ecological study.
    Zhao S; Peng Z; Wang MH
    Pathog Glob Health; 2022 May; 116(3):137-139. PubMed ID: 34928191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.
    Dhama K; Nainu F; Frediansyah A; Yatoo MI; Mohapatra RK; Chakraborty S; Zhou H; Islam MR; Mamada SS; Kusuma HI; Rabaan AA; Alhumaid S; Mutair AA; Iqhrammullah M; Al-Tawfiq JA; Mohaini MA; Alsalman AJ; Tuli HS; Chakraborty C; Harapan H
    J Infect Public Health; 2023 Jan; 16(1):4-14. PubMed ID: 36446204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.
    de Rioja VL; Perramon-Malavez A; Alonso S; Andrés C; Antón A; Bordoy AE; Càmara J; Cardona PJ; Català M; López D; Martí S; Martró E; Saludes V; Prats C; Alvarez-Lacalle E
    Front Public Health; 2024; 12():1339267. PubMed ID: 38855458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant model.
    Haschka T; Vergu E; Roche B; Poletto C; Opatowski L
    BMC Infect Dis; 2022 Nov; 22(1):815. PubMed ID: 36324075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 outbreak trends in South Africa: A comparison of Omicron (B.1.1.529), Delta (B.1.617.2), and Beta (B.1.351) variants outbreak periods.
    Al Hasan SM; Saulam J; Mikami F; Kanda K; Yokoi H; Hirao T
    J Infect Public Health; 2022 Jul; 15(7):726-733. PubMed ID: 35687982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Omicron the last SARS-CoV-2 Variant of Concern?
    Rahimi F; Talebi Bezmin Abadi A
    Arch Med Res; 2022 Apr; 53(3):336-338. PubMed ID: 35093242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.
    Niu Y; Luo L; Yang S; Abudurusuli G; Wang X; Zhao Z; Rui J; Li Z; Deng B; Liu W; Zhang Z; Li K; Liu C; Li P; Huang J; Yang T; Wang Y; Chen T; Li Q
    Front Public Health; 2022; 10():949594. PubMed ID: 36187650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
    Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
    BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insights into SARS-CoV-2 omicron variant.
    Silva SJRD; Kohl A; Pena L; Pardee K
    Rev Med Virol; 2023 Jan; 33(1):e2373. PubMed ID: 35662313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion.
    Grabowski F; Kochańczyk M; Lipniacki T
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in research of 2019-nCoV Omicron variant].
    Huang Y; Li YH; Xie SL; Rong ZH; Li BS; Kang M; Deng AP; Li Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):655-662. PubMed ID: 35589568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.